Johnson & Johnson released the transcript of its Third Quarter 2025 Earnings Conference Call, held on October 14, 2025. The event featured key members of the company's leadership team, including the Chairman and CEO, the Chief Financial Officer, the Executive Vice President of Pharmaceuticals, and the Worldwide Chairman of MedTech. The call was attended by several analysts from leading financial institutions. During the call, Johnson & Johnson's management reviewed the company's third-quarter business results and provided an updated financial outlook. They highlighted ongoing pioneering treatments and strategies aimed at transforming lives. Management emphasized their commitment to innovation and market leadership, stating, "We are focused on pioneering treatments that are going to transform lives." The team also discussed the company's future operating and financial performance, market position, and business strategy, cautioning that forward-looking statements are subject to risks and uncertainties. The full transcript can be accessed through the link below.